<PAGE> 1
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report January 12, 1998
----------------
(Date of earliest event reported)
COLLABORATIVE CLINICAL RESEARCH, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Ohio (000-20699) 34-1685364
- ------------------------------- --------------------- ------------------
(State or other jurisdiction of (Commission File No.) (I.R.S. Employer
incorporation) Identification No.)
20600 Chagrin Boulevard, Cleveland, Ohio 44122
- ----------------------------------------------- -----------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (216) 491-9930
--------------
Page 1 of 3 pages
Exhibit Index Appears on Page 3
<PAGE> 2
Item 5. Other Events
- ----------------------
On January 12, 1998, DataTRAK, Inc. (a wholly owned subsidiary of Collaborative
Clinical Research, Inc.), announced that it has acquired electronic data
collection software known as OpusTwo from EDS. The software was originally
developed by Padcom Clinical Research GmbH, a subsidiary of EDS Germany, and has
been used in clinical studies in Europe.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COLLABORATIVE CLINICAL RESEARCH, INC.
By: /s/ Terry C. Black
-------------------------------------------
Terry C. Black
Vice President of Finance, Chief Financial
Officer, Treasurer, and Assistant Secretary
Date: January 26, 1998
Page 2 of 3 Pages
<PAGE> 3
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION PAGE
----------- ----------- ----
99 Press Release Issued by the Company
on January 12, 1998.
Page 3 of 3 Pages
<PAGE> 1
FOR IMMEDIATE RELEASE:
DATATRAK, INC. ACQUIRES OPUSTWO SOFTWARE
Cleveland, Ohio, -- January 12, 1998 -- DataTRAK, Inc., (DataTRAK) the
innovative provider of clinical data collection services for pharmaceutical
research and development, announced today that it has acquired, from EDS, the
electronic data collection software known as OpusTwo, which was originally
developed by Padcom Clinical Research GmbH, a subsidiary of EDS Germany. Data
collection software developed by Padcom Clinical Research has been used in more
than thirty clinical studies in Europe encompassing more than 500 sites and
involving approximately 3,000 patients.
"I am pleased to make today's announcement," said Patrick G.
Chassaigne, President of DataTRAK, Inc. "The OpusTwo software complements our
unique DataTRAKSM process, enabling us to better serve our pharmaceutical
customers' needs."
DataTRAK will continue to work to develop the DataTRAKSM process. The
DataTRAKSM process uses software and connectivity among a network of
investigative sites to improve the quality, efficiency and timeliness of the
clinical research process. It can also be applied to expedite noninterventional
health care data collection including outcomes assessment, pharmacoeconomics and
disease management initiatives.
DataTRAK, Inc., is a wholly owned subsidiary of Collaborative Clinical
Research, Inc. (NASDAQ: CCLR). Collaborative manages a network comprised of over
540 affiliated multitherapeutic clinical research sites providing access to over
3,700 principal investigators in the United States, Canada and the United
Kingdom. In addition, Collaborative operates four research facilities, conducts
Phase I through Phase IV clinical research and provides clinical reference
laboratory and Institutional Review Board services.
CONTACTS: Patrick G. Chassaigne Philip A. Stark
President Vice President, Corporate Development
DataTRAK, Inc. Collaborative Clinical Research, Inc.
(216) 921-6505 (216) 491-9930
